NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CAMP4

CAMP4

Public
Cambridge, MassachusettsBiotechwww.camp4tx.com

CAMP4 is now publicly traded

The data on this page reflects CAMP4's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Follow-on Offering

Dec 18, 2025

Est. Valuation at Exit

$311.28M

Total Funding Raised

$255M

Company Overview

CAMP4 is a biopharmaceutical company specializing in the discovery and development of regulatory RNA-based therapeutics aimed at enhancing gene expression and restoring healthy protein levels to address genetic diseases, particularly those affecting the central nervous system and liver.

Sector

Biotech

AI Layer

Non-AI

Keywords

RNA Actuating Platform (RAP)regulatory RNA (regRNA)-based therapeuticsgene expression upregulation therapeuticsantisense oligonucleotide (ASO) drug candidatesregRNA target discovery platformoligonucleotide therapeutic developmenttherapeutics for haploinsufficient disorderstherapeutics for rare genetic CNS diseasestherapeutics for rare genetic liver diseasesdrug discovery for protein deficienciesbiopharma strategic collaboration modelclinical-stage biopharmaceutical company

CAMP4 Comparables

Compare CAMP4 with similar companies based on industry and business-model similarity.

CAMP4 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

CAMP4 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingDec 18, 2025
Private PlacementSep 10, 2025
Series BJul 20, 2022
Series A ExtensionJun 15, 2021
Series AApr 20, 2018
View all Funding Rounds

CAMP4 Investors

Notable investors and investment history

CAMP4 investors
InvestorRounds
EcoR1 CapitalFollow-on Offering
Andreessen HorowitzSeries A Extension, Series B, Series A
Enavate SciencesSeries B
Janus Henderson GroupPrivate Placement, Follow-on Offering
Balyasny Asset Management L.P.Private Placement
GaingelsSeries B
Patient Square CapitalSeries B
View all Investors

CAMP4 Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CAMP4 Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range61
Year Founded2018
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.